These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9328133)

  • 41. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE.
    Bäck O; Scheynius A; Johansson SG
    Arch Dermatol Res; 1995; 287(5):448-51. PubMed ID: 7625855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
    Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
    Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis.
    Furue M; Koga T; Yamashita N
    Br J Dermatol; 1999 Jan; 140(1):67-72. PubMed ID: 10215770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
    Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
    Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different serum interleukin-12 and sCD30 levels in food- and pollen-sensitized children.
    Blanco Quirós A; Arranz E; Hoyos C; Carrasco JA; Andión R
    Pediatr Allergy Immunol; 1999 Nov; 10(4):235-40. PubMed ID: 10678718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic.
    Tanaka M; Aiba S; Matsumura N; Aoyama H; Tagami H
    Dermatology; 1995; 190(4):269-76. PubMed ID: 7655104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
    Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
    Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
    Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
    Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
    Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between serum IL-16 and atopic dermatitis.
    Zheng HY; Zhao L; Li CX; Li SH
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
    Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
    J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
    Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases.
    Navikas V; Martin C; Matusevicius D; Söderström M; Fredrikson S; Link H
    Acta Neurol Scand; 1997 Feb; 95(2):99-102. PubMed ID: 9059729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
    Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
    J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
    Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
    Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.
    Pizzolo G; Vinante F; Morosato L; Nadali G; Chilosi M; Gandini G; Sinicco A; Raiteri R; Semenzato G; Stein H
    AIDS; 1994 Jun; 8(6):741-5. PubMed ID: 8086130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels.
    Esnault S; Benbernou N; Lavaud F; Guenounou M
    Clin Exp Immunol; 1996 Oct; 106(1):67-72. PubMed ID: 8870700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High serum level of soluble CD30 in acute primary HIV-1 infection.
    Pizzolo G; Vinante F; Nadali G; Krampera M; Morosato L; Chilosi M; Raiteri R; Sinicco A
    Clin Exp Immunol; 1997 May; 108(2):251-3. PubMed ID: 9158093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.